Local MP David Rutley welcomed the announcement that Hematogenix, a US-based molecular services firm, has chosen to locate its new facility at Alderley Park. He met senior figures from the company at a recent launch event.
Hematogenix, based in Chicago, specialises in cancer-related testing services and has chosen to base its newest laboratories in North East Cheshire. Hematogenix selected the Alderley Park site over facilities in London, Oxford, Cambridge, Nottingham and Scotland, due to the area’s reputation as an industry leader in the life science sector.
The company’s move will be the first direct foreign investment in the Alderley Park site and the firm’s Chief Executive, Dr Hytham Al-Masri predicts that the facility will create up to 15 jobs in the first year, and 50 jobs over the next three years.
After meeting with Dr Al-Masri David said, ‘Hematogenix’s expansion onto the Alderley Park site represents a real vote of confidence in the science park. The new facilities will be seeking to recruit from the local area, which is a testament to the talent and expertise that our local communities boast. As a member of the Alderley Park Task Force, I am pleased to see this further positive progress.’